Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Morin

Cell cycle inhibitor
 
ALX-385-016-G001 1 g 36.00 USD
Do you need bulk/larger quantities?
 
Antioxidant flavonoid. Shows anti-proliferative and antitumor properties. Induces apoptosis. Induces cell cycle arrest at the G2/M phase. Anti-inflammatory compound. Suppresses NF-κB activation. Induces lipid peroxidation and DNA strand breaks.

Product Specification

Alternative Name:2’,3,4’,5,7-Pentahydroxyflavone
 
Formula:C15H10O7
 
MW:302.2
 
CAS:654055-01-3
 
MI:14: 6269
 
RTECS:LK8749000
 
Purity:≥85% (HPLC)
 
Appearance:Yellow to brown.
 
Solubility:Soluble in methanol or 100% ethanol; slightly soluble in ether or acetic acid.
 
Shipping:Ambient
 
Long Term Storage:Ambient
 
alx-385-016
Please mouse over
alx-385-016

Product Literature References

Morin (3,5,7,2’,4’-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosi: S.K. Manna, et al.; Clin. Cancer Res. 13, 2290 (2007), Abstract;
Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway: H.M. Kuo, et al.; Anticancer Res. 27, 395 (2007), Abstract;
Lipid peroxidation and DNA damage induced by morin and naringenin in isolated rat liver nuclei: S. C. Sahu & G. C. Gray; Food Chem. Toxicol. 35, 443 (1997), Abstract;
Structure-antioxidant activity relationships of flavonoids and phenolic acids: C.A. Rice-Evans, et al.; Free Radic. Biol. Med. 20, 933 (1996), (Review), Abstract;

Related Literature

Brochures
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,